APA (7th ed.) Citation

Lemech, C., Kichenadasse, G., Teng, C., Nagrial, A., Richardson, G., Humphries, T., . . . Cosman, R. (2024). 676TiP MYE Symphony: A first-in-human study to investigate the safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of the in vivo mRNA CAR therapy, MT-302, targeting TROP2 in adults with advanced epithelial tumors. Annals of Oncology, 35, S528. https://doi.org/10.1016/j.annonc.2024.08.742

Chicago Style (17th ed.) Citation

Lemech, C., et al. "676TiP MYE Symphony: A First-in-human Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the in Vivo MRNA CAR Therapy, MT-302, Targeting TROP2 in Adults with Advanced Epithelial Tumors." Annals of Oncology 35 (2024): S528. https://doi.org/10.1016/j.annonc.2024.08.742.

MLA (9th ed.) Citation

Lemech, C., et al. "676TiP MYE Symphony: A First-in-human Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the in Vivo MRNA CAR Therapy, MT-302, Targeting TROP2 in Adults with Advanced Epithelial Tumors." Annals of Oncology, vol. 35, 2024, p. S528, https://doi.org/10.1016/j.annonc.2024.08.742.